As part of the SENTRY Antimicrobial Surveillance Program in 2002, five multidrug-resistant Pseudomonas aeruginosa clinical isolates were detected with metallo--lactamase (ML) activity. The isolates were recovered from different patients in a medical center located in Dusseldorf, Germany. The resistant determinant was isolated amplifying the region between the integrase and the aacA4 gene cassette. Sequencing revealed a novel ML gene, designated bla GIM-1 . Additional analysis showed that GIM-1, comprising 250 amino acids and with a pI value of 5.4, differs in its primary sequence from that described for IMP, VIM, and SPM-1 enzymes by 39 to 43%, 28 to 31%, and 28%, respectively. The enzyme possesses unique amino acids within the major consensus sequence (HXHXD) of the ML family. Kinetics analysis revealed that GIM-1 has no clear preference for any substrate and did not hydrolyze azlocillin, aztreonam, and the serine--lactamase inhibitors. bla GIM-1 was found on a 22-kb nontransferable plasmid. The new ML gene was embedded in the first position of a 6-kb class 1 integron, In77, with distinct features, including an aacA4 cassette downstream of the ML gene that appeared to be truncated with bla GIM-1 . The aacA4 was followed by an aadA1 gene cassette that was interrupted by a copy of the IS1394. This integron also carried an oxacillinase gene, bla OXA-2 , before the 3-CS region. GIM-1 appears to be a unique ML, which is located in a distinct integron structure, and represents the fourth subclass of mobile ML enzymes to be characterized.Pseudomonas aeruginosa is a leading cause of nosocomial infections, giving rise to a wide range of life-threatening conditions. Its intrinsic resistance to many antimicrobial agents and its ability to develop multidrug resistance imposes a serious therapeutic problem (8). Carbapenems are very useful antimicrobial agents for the treatment of infections caused by P. aeruginosa; however, increasing use of these compounds has resulted in the development of carbapenem-resistant P. aeruginosa. Mechanisms of resistance to carbapenems in P. aeruginosa are associated with reduced uptake of the agent resulting from the loss or reduced expression of the OprD porin, combined with derepression of the chromosomal ampC -lactamase gene (23); overexpression of an efflux pump system (22, 37); and production of a metallo--lactamase (ML) (16).The first mobile ML (IMP-1) was found in P. aeruginosa in Japan in the early 1990s (33). For many years, the occurrence of IMP-1-producing bacteria was confined to Japan. More recently, however, IMP-1 and IMP-variant enzymes have been reported from many other countries and across four continents (6,9,12,13,24,27). Since the emergence of IMP-1, two other subclasses of clinically relevant MLs have been described: the VIM series (15) and SPM-1 (29). VIM variants are now found throughout the world as well (2,13,17,20,21,30,32,34,35), whereas SPM-1 thus far seems to be restricted to Brazil.We characterize here a novel subclass of Ambler class B enzyme, GIM-...